AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32615109 — intervention group
Group type: COMPARATOR
Intervention: Non-transplantation therapies (control group)
Number of subjects: 45
Study 34289086 — intervention group
Group type: EXPERIMENTAL
Intervention: Difamilast 0.3%
Number of subjects: 251
Study 34289086 — intervention group
Group type: EXPERIMENTAL
Intervention: Difamilast 1%
Number of subjects: 251
Study 34289086 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 251
Study 33794205 — intervention group
Group type: EXPERIMENTAL
Intervention: Avelumab plus chemoradiotherapy (10 mg/kg avelumab intravenously every 2 weeks plus 100 mg/m2 cisplatin every 3 weeks plus intensity‐modulated radiotherapy with standard fractionation of 70 Gy)
Number of subjects: 697
Study 33794205 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus chemoradiotherapy (placebo group)
Number of subjects: 697
Study 33794205 — intervention group
Group type: EXPERIMENTAL
Intervention: Avelumab
Number of subjects: 697
Study 33794205 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 697
Study 35099133 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual Nitroglycerin (NTG) administration
Number of subjects: 77
Study 32964215 — intervention group
Group type: EXPERIMENTAL
Intervention: Ustekinumab (130 mg intravenous induction, then 90 mg subcutaneous maintenance every 8/12 weeks)
Number of subjects: 2574
Study 32964215 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2574
Study 32964215 — intervention group
Group type: EXPERIMENTAL
Intervention: Ustekinumab
Number of subjects: 2574
Study 35361578 — intervention group
Group type: EXPERIMENTAL
Intervention: CT perfusion
Number of subjects: 24
Study 35361578 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic contrast‐enhanced MR imaging
Number of subjects: 24
Study 34114999 — intervention group
Group type: EXPERIMENTAL
Intervention: Rational emotive education (REE) program
Number of subjects: 150
Study 34114999 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 150
Study 35218455 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm 1: three consecutive monthly aflibercept injections followed by bimonthly treatment until week 52, then treat-and-extend regimen
Number of subjects: 41
Study 35218455 — intervention group
Group type: COMPARATOR
Intervention: Arm 2: treated according to a treat-and-extend protocol throughout the 18-month follow-up
Number of subjects: 41
Study 32384437 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT) - 3 times once per week (n=40)
Number of subjects: 80
Study 32384437 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroid injection (CSI) - a single 1-mL dose of betamethasone sodium plus 0.5 mL of prilocaine under ultrasound guidance (n=40)
Number of subjects: 80
Study 32384437 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT)
Number of subjects: 80
Study 32384437 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroid injection (CSI)
Number of subjects: 80
Study 34315730 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer Navigator Direct Distribution (PND)
Number of subjects: 4163
Study 34315730 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 4163
Study 34315730 — intervention group
Group type: COMPARATOR
Intervention: Incentivised Peer Networks (IPN)
Number of subjects: 4163
Study 33213378 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg/day tolvaptan
Number of subjects: 530
Study 33213378 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5 mg/day tolvaptan
Number of subjects: 530
Study 33213378 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolvaptan (both dosages)
Number of subjects: 530
Study 33213378 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 530
Study 35581310 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning school timing (07:45 a.m.-12:05 p.m.)
Number of subjects: 259
Study 35581310 — intervention group
Group type: EXPERIMENTAL
Intervention: Afternoon school timing (12:40 p.m.-05:00 p.m.)
Number of subjects: 259
Study 35581310 — intervention group
Group type: EXPERIMENTAL
Intervention: Evening school timing (05:20 p.m.-09:40 p.m.)
Number of subjects: 259
Study 35581310 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline chronotype
Number of subjects: 259
Study 32234934 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecystectomy
Number of subjects: 144
Study 32234934 — intervention group
Group type: COMPARATOR
Intervention: No cholecystectomy (Control)
Number of subjects: 144
Study 35732345 — intervention group
Group type: EXPERIMENTAL
Intervention: Febuxostat
Number of subjects: 6190
Study 35732345 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 6190
Study 35732345 — intervention group
Group type: COMPARATOR
Intervention: Febuxostat or Allopurinol (discontinuation)
Number of subjects: 6190
Study 32935453 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacteriostatic saline (0.9% benzyl alcohol)
Number of subjects: 68
Study 32935453 — intervention group
Group type: COMPARATOR
Intervention: Buffered 1% lidocaine
Number of subjects: 68
Study 35564611 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term intensive-type Cognitive Behavioral Therapy (CBT) intervention
Number of subjects: 43
Study 35564611 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 43
Study 33526287 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral Nutrition (EN)
Number of subjects: 87
Study 33526287 — intervention group
Group type: COMPARATOR
Intervention: Parenteral Nutrition (PN)
Number of subjects: 87
Study 33526287 — intervention group
Group type: EXPERIMENTAL
Intervention: Low SMI after neoadjuvant chemotherapy
Number of subjects: 87
Study 34312159 — intervention group
Group type: EXPERIMENTAL
Intervention: 1500 mg calcium propionate (PA)
Number of subjects: 28
Study 34312159 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 32895660 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium 200 mcg tablets twice daily
Number of subjects: 71
Study 32895660 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study 34397746 — intervention group
Group type: EXPERIMENTAL
Intervention: Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) once daily
Number of subjects: 495
Study 34397746 — intervention group
Group type: COMPARATOR
Intervention: Stay on baseline regimen (SBR)
Number of subjects: 495
Study 35076721 — intervention group
Group type: EXPERIMENTAL
Intervention: LSD
Number of subjects: 142
Study 35076721 — intervention group
Group type: EXPERIMENTAL
Intervention: Psilocybin
Number of subjects: 142
Study 35076721 — intervention group
Group type: EXPERIMENTAL
Intervention: Both LSD and Psilocybin
Number of subjects: 142
Study 35076721 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 142
Study 33608814 — intervention group
Group type: EXPERIMENTAL
Intervention: ubrogepant 50 mg
Number of subjects: 2240
Study 33608814 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 2240
Study 34972657 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 120
Study 34972657 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular analgesia
Number of subjects: 120
Study 32744221 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate cognitive behavioural therapy (CBT)
Number of subjects: 7
Study 32744221 — intervention group
Group type: COMPARATOR
Intervention: Wait-list (WL)
Number of subjects: 7
Study 32744221 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed CBT (after WL)
Number of subjects: 7
Study 35604034 — intervention group
Group type: EXPERIMENTAL
Intervention: Rural participants
Number of subjects: 2539
Study 35604034 — intervention group
Group type: COMPARATOR
Intervention: Urban and suburban participants
Number of subjects: 2539
Study 34689863 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose urokinase (50,000 IU injected daily, total 100,000 IU per day)
Number of subjects: 60
Study 34689863 — intervention group
Group type: COMPARATOR
Intervention: Control group (20,000 IU injected daily, total 40,000 IU per day)
Number of subjects: 60
Study 34689863 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose urokinase treatment
Number of subjects: 60
Study 34689863 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 32807219 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic-arm assisted unicompartmental knee arthroplasty (RO UKA)
Number of subjects: 140
Study 32807219 — intervention group
Group type: COMPARATOR
Intervention: Conventional jig-based unicompartmental knee arthroplasty (CO UKA)
Number of subjects: 140
Study 36327261 — intervention group
Group type: EXPERIMENTAL
Intervention: Online education and game-based virtual reality phone applications
Number of subjects: 126
Study 36327261 — intervention group
Group type: COMPARATOR
Intervention: Traditional education
Number of subjects: 126
Study 33835822 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-gene GPS assay
Number of subjects: 200
Study 33835822 — intervention group
Group type: COMPARATOR
Intervention: Standard counseling
Number of subjects: 200
Study 36411103 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard nail (240 mm)
Number of subjects: 182
Study 36411103 — intervention group
Group type: COMPARATOR
Intervention: Long nail
Number of subjects: 182
Study 32475360 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (1250 µg per week for 2 months)
Number of subjects: 100
Study 32475360 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 36242578 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumor resection
Number of subjects: 101
Study 36242578 — intervention group
Group type: COMPARATOR
Intervention: Biopsy
Number of subjects: 101
Study 32991046 — intervention group
Group type: COMPARATOR
Intervention: L-phenylalanine (10 g)
Number of subjects: 16
Study 32991046 — intervention group
Group type: COMPARATOR
Intervention: D-phenylalanine (10 g)
Number of subjects: 16
Study 32028315 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramedullary nailing
Number of subjects: 240
Study 32028315 — intervention group
Group type: COMPARATOR
Intervention: External fixation
Number of subjects: 240
Study 34798474 — intervention group
Group type: EXPERIMENTAL
Intervention: Body positive content with captions
Number of subjects: 233
Study 34798474 — intervention group
Group type: EXPERIMENTAL
Intervention: Body positive content without captions
Number of subjects: 233
Study 34798474 — intervention group
Group type: COMPARATOR
Intervention: Cityscape images (Control)
Number of subjects: 233
Study 34732661 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced recovery after surgery based on pre-operative rehabilitation (group PR-ERAS)
Number of subjects: 213
Study 34732661 — intervention group
Group type: COMPARATOR
Intervention: Standardized enhanced recovery after surgery (group S-ERAS)
Number of subjects: 213
Study 36379593 — intervention group
Group type: EXPERIMENTAL
Intervention: ciKMC
Number of subjects: 4475
Study 36379593 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 4475
Study 35717263 — intervention group
Group type: EXPERIMENTAL
Intervention: tranexamic acid
Number of subjects: 0
Study 35578304 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib 2 mg
Number of subjects: 0
Study 35578304 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib 4 mg
Number of subjects: 0
Study 35578304 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33069881 — intervention group
Group type: EXPERIMENTAL
Intervention: Ornithine phenylacetate (OP) 10, 15, or 20 g/d
Number of subjects: 231
Study 33069881 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 231
Study 33415852 — intervention group
Group type: EXPERIMENTAL
Intervention: Crossing nape electroacupuncture (EA)
Number of subjects: 160
Study 33415852 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 160
Study 33415852 — intervention group
Group type: EXPERIMENTAL
Intervention: Nape EA
Number of subjects: 160
Study 33415852 — intervention group
Group type: COMPARATOR
Intervention: Model group (control)
Number of subjects: 160
Study 33415852 — intervention group
Group type: COMPARATOR
Intervention: Normal group (control)
Number of subjects: 160
Study 35679098 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide 2 mg once weekly
Number of subjects: 83
Study 35679098 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study 33901056 — intervention group
Group type: EXPERIMENTAL
Intervention: rtfMRI-NF training with functional connectivity information
Number of subjects: 14
Study 33901056 — intervention group
Group type: COMPARATOR
Intervention: rtfMRI-NF training using neuronal activity as the neurofeedback signal
Number of subjects: 14
Study 33112697 — intervention group
Group type: EXPERIMENTAL
Intervention: 1Hz repetitive transcranial magnetic stimulation (rTMS) applied to the right inferior frontal gyrus (rIFG)
Number of subjects: 0
Study 33112697 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 0
Study 33112697 — intervention group
Group type: COMPARATOR
Intervention: Post-hoc comparison of real rTMS first vs. sham first
Number of subjects: 0
Study 35099356 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic training
Number of subjects: 36
Study 35099356 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot‐assisted laparoscopic training
Number of subjects: 36
Study 35099356 — intervention group
Group type: EXPERIMENTAL
Intervention: Open surgery training
Number of subjects: 36
Study 34214867 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebrolysin (intravenous as add-on therapy)
Number of subjects: 0
Study 34214867 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 0
Study 35722458 — intervention group
Group type: COMPARATOR
Intervention: Full Range of Motion (fROM) exercises
Number of subjects: 36
Study 35722458 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial Range of Motion (pROM) exercises
Number of subjects: 36
Study 33840086 — intervention group
Group type: EXPERIMENTAL
Intervention: Holmium LASER resection of the bladder tumor (HoLRBT)
Number of subjects: 88
Study 33840086 — intervention group
Group type: COMPARATOR
Intervention: Transurethral resection of bladder tumor (TURBT)
Number of subjects: 88
Study 35332846 — intervention group
Group type: EXPERIMENTAL
Intervention: Sauna (70°C, 18% RH) for ≤40 min
Number of subjects: 25
Study 35332846 — intervention group
Group type: EXPERIMENTAL
Intervention: Hot-water immersion (HWI) (40°C) for ≤40 min
Number of subjects: 25
Study 33027046 — intervention group
Group type: EXPERIMENTAL
Intervention: General Anesthesia (GA)
Number of subjects: 40
Study 33027046 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal Anesthesia (SA)
Number of subjects: 40
Study 36341885 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (75 mg daily)
Number of subjects: 5712
Study 36341885 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5712
Study 34444389 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual suboccipital inhibition technique (MSIT)
Number of subjects: 96
Study 34444389 — intervention group
Group type: EXPERIMENTAL
Intervention: Instrumental suboccipital inhibition (INYBI)
Number of subjects: 96
Study 34444389 — intervention group
Group type: EXPERIMENTAL
Intervention: Instrumental suboccipital inhibition plus upper cervical manipulation technique (INYBI + UCMT)
Number of subjects: 96
Study 34444389 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 96
Study 35152509 — intervention group
Group type: EXPERIMENTAL
Intervention: OneShape rotary system (Micro Mega, Besancon, France)
Number of subjects: 164
Study 35152509 — intervention group
Group type: COMPARATOR
Intervention: WaveOne Gold reciprocating system (Dentsply Maillefer, Ballaigues, Switzerland)
Number of subjects: 164
Study 34193961 — intervention group
Group type: EXPERIMENTAL
Intervention: Theta-burst stimulation (TBS) targeting the right and left dorsolateral prefrontal cortex; duration: 6 weeks.
Number of subjects: 100
Study 34193961 — intervention group
Group type: COMPARATOR
Intervention: Sham TBS; duration: 6 weeks.
Number of subjects: 100
Study 32810358 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin II receptor blocker (ARB)
Number of subjects: 64
Study 32810358 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 36561412 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% glycolic acid
Number of subjects: 120
Study 36561412 — intervention group
Group type: COMPARATOR
Intervention: 30% salicylic acid
Number of subjects: 120
Study 35667076 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib plus standard of care
Number of subjects: 0
Study 35667076 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (placebo)
Number of subjects: 0
Study 32027547 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasmalyte
Number of subjects: 28
Study 32027547 — intervention group
Group type: COMPARATOR
Intervention: Ringer lactate (RL)
Number of subjects: 28
Study 36646986 — intervention group
Group type: EXPERIMENTAL
Intervention: Ti‐reinforced d‐PTFE membrane
Number of subjects: 40
Study 36646986 — intervention group
Group type: COMPARATOR
Intervention: Ti-mesh covered with collagen membrane
Number of subjects: 40
Study 34088818 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary approach (immediate start)
Number of subjects: 111
Study 34088818 — intervention group
Group type: COMPARATOR
Intervention: Delayed intervention (6-month delay)
Number of subjects: 111
Study 35587322 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited adjuvant tamoxifen treatment
Number of subjects: 135
Study 35587322 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-risk classification
Number of subjects: 135
Study 35587322 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk classification
Number of subjects: 135
Study 35587322 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultralow-risk classification
Number of subjects: 135
Study 33847313 — intervention group
Group type: EXPERIMENTAL
Intervention: Bempedoic acid (ETC‐1002)
Number of subjects: 0
Study 32078609 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence-based cancer pain management strategies
Number of subjects: 64
Study 32078609 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of primary pain characteristics and management of opioid-induced constipation with a bowel regimen
Number of subjects: 64
Study 34247471 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive and motor training (CMT) for visual-motor integration, 6 sessions over 2 weeks
Number of subjects: 63
Study 34247471 — intervention group
Group type: COMPARATOR
Intervention: Empty control group (no intervention) for 2 weeks
Number of subjects: 63
Study 34247471 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive and motor training (CMT) for visual-motor integration, 6 sessions over 2 weeks (after crossover)
Number of subjects: 63
Study 34708706 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical lidocaine spray only
Number of subjects: 240
Study 34708706 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral naproxen only
Number of subjects: 240
Study 34708706 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical lidocaine spray and naproxen tablet
Number of subjects: 240
Study 34708706 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 240
Study 33377367 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (10 mg daily for 4 months)
Number of subjects: 826
Study 33377367 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (200,000 IU)
Number of subjects: 826
Study 33377367 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc plus Vitamin A supplementation
Number of subjects: 826
Study 33377367 — intervention group
Group type: COMPARATOR
Intervention: Placebo (no zinc, no vitamin A)
Number of subjects: 826
Study 35263436 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg/day for 120 days
Number of subjects: 30
Study 32367378 — intervention group
Group type: EXPERIMENTAL
Intervention: Zn-Methionine (Zn-Met)
Number of subjects: 160
Study 32367378 — intervention group
Group type: EXPERIMENTAL
Intervention: Zn-Threonine (Zn-Thr)
Number of subjects: 160
Study 32367378 — intervention group
Group type: COMPARATOR
Intervention: ZnO 30 mg Zn/kg
Number of subjects: 160
Study 32367378 — intervention group
Group type: COMPARATOR
Intervention: ZnO 60 mg Zn/kg
Number of subjects: 160
Study 32367378 — intervention group
Group type: COMPARATOR
Intervention: Control diet (30.3 mg Zn/kg diet)
Number of subjects: 160
Study 32367378 — intervention group
Group type: EXPERIMENTAL
Intervention: Zn content in egg and excreta
Number of subjects: 160
Study 36071990 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-incisional laparoscopic preperitoneal local anesthetic technique (PLPLAT)
Number of subjects: 120
Study 36071990 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 33795116 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose everolimus and low-dose tacrolimus (RADTAC group)
Number of subjects: 40
Study 33795116 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose tacrolimus (TAC group)
Number of subjects: 40
Study 36414368 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentive spirometry (IS)
Number of subjects: 40
Study 36414368 — intervention group
Group type: COMPARATOR
Intervention: Deep breathing exercises (DBE)
Number of subjects: 40
Study 32008286 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tACS (77.5 Hz, 15 mA, 40 minutes/session, 20 sessions over 4 weeks)
Number of subjects: 30
Study 32008286 — intervention group
Group type: COMPARATOR
Intervention: Sham intervention
Number of subjects: 30
Study 32008286 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tACS
Number of subjects: 30
Study 32008286 — intervention group
Group type: COMPARATOR
Intervention: Both groups (Active tACS and Sham)
Number of subjects: 30
Study 35057795 — intervention group
Group type: EXPERIMENTAL
Intervention: Liaison nurse management program
Number of subjects: 80
Study 35057795 — intervention group
Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 80
Study 32314543 — intervention group
Group type: EXPERIMENTAL
Intervention: ABACS (Automatic Body composition Analyser using Computed tomography image Segmentation)
Number of subjects: 5988